For tendon, intestinal, or gastrointestinal models, BPC-157 has the largest literature base (35 AJSM 2026 studies + Sikiric corpus)
The best way to treat vitamin B12 deficiency is through diet and supplementation
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
Regenorix supplies BPC-157 exclusively for laboratory and analytical research and every vial we ship is backed by hard proof, not marketing language
Each warm-cold cycle is a small stress event